DUBLIN–(BUSINESS WIRE)–The “Global
Hyaluronic Acid Market Size, Share & Trends Analysis Report 2019”
report has been added to ResearchAndMarkets.com’s
offering.
The global hyaluronic acid market size is expected to reach USD 15.25
billion by 2026 registering a CAGR of 7.8%.
Factors, such as increasing concern about toxic chemicals, need for
quick and evident results, and shorter recovery time are high impact
rendering drivers of this market. The market is witnessing rapid growth
due to increasing adoption of aesthetic procedures across the globe.
Wide usage of hyaluronic acid surfaces in cardiovascular implants, such
as stents and vascular grafts, for improving the compatibility coupled
with growing awareness about anti-aging products is driving the market.
In addition, increasing cases of obesity indicate a rising number of
people suffering from orthopedic disorders, which do not have any
permanent cure and the treatments include pain-killers. However,
hyaluronic acid-based viscosupplements are expected to be a possible
cure for joint pain. Orthovisc, approved in 2013, and Monovisc, approved
in 2016, by Anika Therapeutics, Inc. are among the popular
viscosupplements.
Increasing popularity of cosmetic surgeries across the globe is also
expected to boost the market growth. In 2013, hyaluronan-based facial
fillers received FDA approval, which is used in corrective measures,
anti-aging procedure, and filling fine lines. North America led the
market in 2018. Presence of key companies, such as Genzyme Corporation
and Anika Therapeutics, in this region contributes to market growth.
Increasing number of anti-aging procedures performed and resultant
demand for dermal fillers are expected to drive the regional market
further.
Further key findings from the study suggest:
-
Rising cases of obesity resulting in increased number of cases of
osteoarthritis and joint pain has boosted the demand for hyaluronic
acid injections as treatment. -
According to the studies, the number of people suffering from
osteoarthritis is expected to grow from 53 million in 2012 to 78
million by 2040. -
Asia-Pacific is anticipated to emerge as the fastest-growing regional
market during the forecast period due to growing geriatric population
in China and Japan, which provides a large customer base for
anti-aging products and services. -
Some of the key companies in the global hyaluronic acid market are F.
Hoffmann-La Roche, Seikagaku Corp, Galderma, Sanofi (Genzyme), Anika
Therapeutics, Salix Pharmaceuticals, Zimmer Holdings, Allergan,
Ferring Pharmaceuticals, and Smith & Nephew.
Key Topics Covered
Chapter 1 Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Application
1.1.2 Regional
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Application
2.2.2 Region
2.2.3 Competitive Insights
2.3 Market Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market segmentation
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & growth prospect mapping
3.4 Hyaluronic Acid Market Analysis Tools
3.4.1 PEST – SWOT Analysis, By Factor (Political & Legal, Economic And
Technological)
3.4.2 Industry Analysis – Porter’s
3.4.3 Major Deals And Strategic Analysis
Chapter 4 Hyaluronic Acid Market: Application Estimates & Trend Analysis
4.1 Hyaluronic Acid market: Application Movement Analysis
4.2 Dermal Fillers
4.2.1 Dermal Fillers Market, 2015 – 2026 (USD Million)
4.3 Osteoarthritis
4.3.1 Osteoarthritis Market, 2015 – 2026 (USD Million)
4.3.2 Single Injection
4.3.3 Three Injection
4.3.4 Five Injection
4.4 Ophthalmic
4.4.1 Ophthalmic Market, 2015 – 2026 (USD Million)
4.5 Vesicoureteral reflux
4.5.1 Vesicoureteral reflux Market, 2015 – 2026 (USD Million)
Chapter 5 Hyaluronic Acid Market: Regional Estimates & Trend Analysis
5.1 Hyaluronic Acid Market Share, by Region, 2018 & 2026
5.2 North America
5.2.1 North America Hyaluronic Acid Market, 2015 – 2026 (USD Million)
5.2.2 U.S.
5.2.3 Canada
5.3 Europe
5.3.1 Europe Hyaluronic Acid Market, 2015 – 2026 (USD Million)
5.3.2 U.K.
5.3.3 Germany
5.3.4 France
5.3.5 Italy
5.3.6 Spain
5.4 Asia Pacific
5.4.1 Asia Pacific Hyaluronic Acid Market, 2015 – 2026 (USD Million)
5.4.2 India
5.4.3 China
5.4.4 Japan
5.5 Latin America
5.5.1 Latin America Hyaluronic Acid Market, 2015 – 2026 (USD Million)
5.5.2 Brazil
5.5.3 Mexico
5.6 MEA
5.5.1 MEA Hyaluronic Acid Market, 2015 – 2026 (USD Million)
5.5.2 South Africa
Chapter 6 Reimbursement Scenario
6.1 Reimbursement by Product
6.1.1 Gel-one
6.1.2 EUFLEXXA
6.1.3 Synvisc-One
6.1.4 Supartz
6.1.5 Hyalgan
6.1.6 Monovisc
6.1.7 Orthovisc
6.1.8 Juvderm, Emervel, Restylane, Macrolane, Belotero, Filorga,
Jalupro, Princess, Teosyal, Stylage, Filorga and others
6.2 Reimbursement by Region
6.2.1 U.S.
6.2.2 Canada
6.2.3 China
6.2.4 Japan
6.2.5 India
6.2.6 Brazil
6.2.7 South Africa
6.2.8 Europe
Chapter 7 Competitive Landscape
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Strategy Framework
7.3 Vendor Landscape
7.4 Company Market Position Analysis (Revenue, Geographic Presence,
Product Portfolio, Strategic Initiatives, Employee Strength)
7.5 Company Profiles
7.5.1 Allergan
7.5.2 Sanofi
7.5.3 Genzyme Corporation
7.5.4 Anika Therapeutics, Inc.
7.5.5 Salix Pharmaceuticals, Inc.
7.5.6 Seikagaku Corporation
7.5.7 F. Hoffmann-La Roche AG
7.5.8 Galderma S.A.
7.5.9 Zimmer Biomet
7.5.10 Smith & Nephew PLC
7.5.11 Ferring B.V.
7.5.12 Lifecore Biomedical, LLC
7.5.13 HTL Biotechnology
7.5.14 Shiseido
7.5.15 Bloomage Freda Biopharm Co. Ltd.
7.5.16 LG Life Sciences Ltd.
7.5.17 Maruha Nichiro, Inc.
7.5.18 Fluidigm Corporation
Chapter 8 Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/8a894b
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs, Cosmetic
Chemicals